familymednews.com
(HealthDay)—There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes, according to a study published in the June 6 issue of the New England Journal of Medicine. Peter D. Reaven, M.D., from the Phoenix Veterans Affairs Health Care System, and colleagues report 15-year follow-up for intensive […]
Continue reading »
The soccer ball is racing at a speed of 80 km/hr when the player uses their head to redirect it and score. Their team wins the game—but at what cost? UBC Okanagan research suggests the price is high. The study shows that repetitive impacts of a soccer ball on a player’s head could cause damage to the cells of the […]
Continue reading »
(HealthDay)—Three experimental Ebola vaccines trigger an immune response that lasts for more than two years against the deadly disease, researchers report. In addition to being welcome news for the Ebola outbreak that’s now spreading throughout the Democratic Republic of Congo, this success story is spurring research into the development of similar vaccines for other infectious diseases, the researchers added. In […]
Continue reading »
A potentially new way of treating cerebral malaria has been discovered by scientists at the Universities of Manchester and Glasgow, in a study using mice. The authors found that inhibiting a complex called the inflammasome, at the same time as delivering anti-malarial drugs, reduced mortality from experimental cerebral malaria in mice. The research, published in PNAS and funded by the […]
Continue reading »
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours. Because tumours are not uniform and different parts of them change at varying speeds, it is difficult for researchers to see what effects their […]
Continue reading »